Infliximab Plus Methotrexate for the Treatment of Rheumatoid Arthritis

Clinical trial NCT00269867 · COMPLETED

Trial details

NCT number: NCT00269867
Sponsor: Centocor, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 1997-03-01
Primary completion: 2000-03-01
Enrollment: 428

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.